ESMO 2025 – Prof. Dent on TROPION-Breast02 Results

Prof. Rebecca Dent presents the much-anticipated primary results from the randomized phase III TROPION-Breast02 trial at ESMO 2025, sharing key outcomes that could redefine treatment strategies in advanced breast cancer.